Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05764005 · ClinicalTrials.gov registry record · NA
Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study
A NA study, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT05764005 is a NA study that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 39 participants.
The verdict
NCT05764005, a NA study, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
This is a pilot evaluation of a patient-centered intervention that enables providers to support men on active surveillance to maximize adherence. Conducted in urology practices, this pilot will measure key patient-reported, provider-reported, and implementation outcomes. Successful completion of this work will inform a subsequent multi-center effectiveness-implementation hybrid design trial and ultimately will improve low-risk cancer management by effectively engaging Primary Care Physicians (PCPs) in care delivery.
Interventions
- BEHAVIORAL web-based tool (MAP- Management of Active surveillance in Prostate Cancer)
- BEHAVIORAL MUSIC website
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2022-11-09 |
| Est. Completion | 2024-03-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05764005
The ClinicalTrials.gov registry entry for NCT05764005 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which web-based tool (MAP- Management of Active surveillance in Prostate Cancer) is the first listed.
NCT05764005 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05764005 about?
NCT05764005 is a clinical study titled "Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study". This is a pilot evaluation of a patient-centered intervention that enables providers to support men on active surveillance to maximize adherence. Conducted in urology practices, this pilot will measure key patient-reported, provider-reported, and implementation outcomes. Successful completion of thi...
What is the current status of trial NCT05764005?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2022-11-09. Estimated completion is 2024-03-11.
What interventions are being tested in trial NCT05764005?
The interventions under investigation include: web-based tool (MAP- Management of Active surveillance in Prostate Cancer) (BEHAVIORAL), MUSIC website (BEHAVIORAL).
Who is sponsoring clinical trial NCT05764005?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.